Effects of cardiovascular agents on respiratory function in COPD patients with concomitant coronary heart disease

L. I. Kozlova, Z. R. Aisanov, A. G. Chuchalin (Moscow, Russia)

Source: Annual Congress 2002 - COPD - Drug therapy 2
Session: COPD - Drug therapy 2
Session type: Thematic Poster Session
Number: 1599
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. I. Kozlova, Z. R. Aisanov, A. G. Chuchalin (Moscow, Russia). Effects of cardiovascular agents on respiratory function in COPD patients with concomitant coronary heart disease. Eur Respir J 2002; 20: Suppl. 38, 1599

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cardiointervalography in COPD patients with concomitant coronary heart disease
Source: Eur Respir J 2005; 26: Suppl. 49, 509s
Year: 2005

Long-term monitoring of respiratory function and influence of selective beta blockers on its decline in COPD patients with concomitant coronary heart disease
Source: Eur Respir J 2001; 18: Suppl. 33, 25s
Year: 2001

Ivabradine prevents salbutamol-induced disturbance of cardiac autonomic regulation in patients with chronic obstructive pulmonary disease and coronary heart disease
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012

The beta-blockers in combined treatment of coronary heart disease in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD treatment
Year: 2013


Alterations in cardiovascular function in COPD and heart failure patients with sarcopenia
Source: Virtual Congress 2020 – Exploring exercise responses in respiratory diseases
Year: 2020

COPD phenotypes not linked to increased risk of coronary heart disease
Source: International Congress 2019 – Comorbidities galore in respiratory patients
Year: 2019




Predictors of coronary heart disease in patients with COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015


Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016

OSA as a cause of cardiovascular disease, including heart failure
Source: ERS Conference
Year: 2015

Elevation of cardiac enzymes in COPD patients with respiratory failures
Source: Annual Congress 2005 - COPD - acute exacerbations
Year: 2005


Prevalence of comorbidities in patients with chronic obstructive pulmonary disease in presence of heart failure
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


The difficulties of functional class heart failure assessment in the patients with concomitant chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010


Hypoxia as a risk factor for arrhythmias in patients with chronic obstructive pulmonary disease and heart failure
Source: International Congress 2019 – More and more COPD
Year: 2019

Beta-blockade therapy in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure in the presence and absence of pulmonary hypertension
Source: Annual Congress 2010 - COPD: management
Year: 2010

Use of metoprolol succinate in patients with cardiovascular diseases associated with asthma or chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 502s
Year: 2006

Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019

Prevalence and characteristics of congestive heart failure in elderly patients with chronic lung disease
Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases
Year: 2009


Respiratory event hospitalizations are reduced in heart failure patients with comorbid chronic obstructive pulmonary disease using a wireless implanted pulmonary artery pressure monitoring system
Source: Annual Congress 2012 - Pulmonary circulation: end-points and biomarkers
Year: 2012


COPD in heart failure patients
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010


Should all chronic obstructive pulmonary disease (COPD) patients with cardiac co-morbidities have ambulatory oxygen assessment?
Source: Annual Congress 2008 - Exercise: system responses
Year: 2008